Not finding it? Sign in to also search OpenAlex live.
-
The impact of emotional distress on pathologic response and survival after neoadjuvant combination immune checkpoint blockade (ICB) in high-risk stage III melanoma.2023 Journal of Clinical Oncology conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access
Irene L. M. Reijers, Itske Fraterman, Petros Dimitriadis, Annegien Broeks, Maria Gonzalez, Alexander Maxwell Menzies, +7 more
3citations -
Abstract P1-10-01: Caveolin gene expression predicts for response and clinical outcomes of patients treated with preoperative paclitaxel-based chemotherapy regimens in early stage breast cancer2020 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Terence Marques Williams, Andreas Schneeweiß, Christian Jackisch, Changxian Shen, Karsten Ernst Weber, Peter Andreas Fasching, +16 more
0citations -
Abstract PS4-08-07: Predicting response and survival after neoadjuvant systemic treatment with on-treatment biopsies2026 Clinical Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
C. Denkert, A. Schneeweiss, V Schaser, Michael Untch, M. Van Mackelenbergh, J.-U. Blohmer, +17 more
0citations -
Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN)
Frank Stegelmann, Lino Lars Teichmann, Florian Heinrich Heidel, Carl C. Crodel, Thomas Ernst, Sebastian Kreil, +11 more
8citations -
Post hoc Analysis of a Randomized, Controlled, Phase 2 Study to Assess Response Rates with Chlormethine/Mechlorethamine Gel in Patients with Stage IA–IIA Mycosis Fungoides
Christiane Querfeld, Julia Jane Scarisbrick, Chalid Assaf, Emmanuella Guenova, Martine Bagot, Pablo Luis Ortiz-Romero, +3 more
20citations -
A prediction model for response to immune checkpoint inhibition in advanced melanoma.2023 Journal of Clinical Oncology conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access
Isabella A.J. van Duin, Rik Jasper Verheijden, P. J. van Diest, Alfonsus Johannes Maria van den Eertwegh, Jan Willem de Groot, Olivier Jules van Not, +14 more
0citations -
AI-detected tumor-infiltrating lymphocytes and response to PD-1 based treatment in advanced melanoma.2025 Journal of Clinical Oncology conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access
Mark Schuiveling, Isabella A.J. van Duin, Janneke C. van der Weerd, Franchette van den Berkmortel, Femke H. Burgers, Marye J. Boers‐Sonderen, +13 more
1citations -
Evaluation of early C-reactive protein kinetics as an early response marker in biliary tract cancer patients treated with combined chemoimmunotherapy.2026 Journal of Clinical Oncology conference-abstract Medicine Cholangiocarcinoma and Gallbladder Cancer Studies Open access
Gabriel Allo, Joshua Leutiger, Catherine Leyh, Christian Moehring, Ann-Kristin Zoeller, Vera Himmelsbach, +10 more
0citations -
MO337: Higher Antibody Response After 2 Vaccinations With MRNA-1273 as Compared With BNT162B2 and AZD1222 in High-Risk Kidney Patients2022 Nephrology Dialysis Transplantation article Medicine SARS-CoV-2 and COVID-19 Research Open access
Pim Bouwmans, A. Lianne Messchendorp, Céline Imhof, Jan‐Stephan Sanders, Luuk B. Hilbrands, Priya Vart, +10 more
0citations -
A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial2020 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Thomas Karn, Tobias Meißner, Karsten Ernst Weber, Christine Solbach, Carsten Denkert, Knut Engels, +19 more
16citations -
Abstract PD5-08: Tumor immune-cell activity assessed by RNAseq is an independent predictor of therapy response and prognosis after neoadjuvant chemotherapy in HER2 negative breast cancer patients - An analysis of the GeparSepto trial2020 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies cited by 1 patent
Peter Andreas Fasching, Carsten Denkert, Stephen Charles Benz, Karsten Ernst Weber, Christopher W. Szeto, Jan Budczies, +17 more
1citations